Multifunctional role of steroidogenic factor 1 and disorders of sex development;Papel multifuncional do fator esteroidogênico 1 e as doenças do desenvolvimento sexual

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 55, Issue 8, 2011, Pages 607-612

  de Mello, Maricilda Palandi ^a   de Souza França, Emerson Salvador ^a   Fabbri, Helena Campos ^a   Maciel Guerra, Andréa Trevas ^a   Guerra Júnior, Gil ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Disorders of sex development; NR5A1 gene; Steroidogenic factor 1

Indexed keywords

NR5A1 PROTEIN, HUMAN; STEROIDOGENIC FACTOR 1;

CHILD; CLASSIFICATION; FEMALE; GENETICS; HUMAN; MALE; MUTATION; REVIEW; SEX DIFFERENTIATION DISORDER;

CHILD; DISORDERS OF SEX DEVELOPMENT; FEMALE; HUMANS; MALE; MUTATION; STEROIDOGENIC FACTOR 1;

EID: 84855437960     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302011000800015     Document Type: Review

References (53)

1. Swain A. Sex determination and differentiation. In: Neill JD, editor. Knobil and Neill's Physiology of Reproduction. 3rd ed. New York: Elsevier; 2006. p. 245-60.
2. Biason-Lauber A. Control of sex development. Best Pract Res Clin Endocrinol Metab. 2010;24(2):163-86.
3. Goodfellow PN, Darling SM. Genetics of sex determination. Development. 1988;102(2):251-8.
4. De-Mello M P, Soardi FC. Genes envolvidos na determinação sexual. In: Maciel-Guerra AT, Guerra-Ju ́nior G, editores. Menino ou menina? Os distúrbios da diferenciação do sexo. 2. ed. São Paulo: Rubio; 2010. p. 3-14.
5. Guerra-Júnior G, Maciel-Guerra AT. The role of the pediatrician in the management of children with genital ambiguities. J Pediatr (Rio J). 2007;83(5 Suppl):S184-91.
6. Hughes IA, Houk C, Ahmed SF, Lee PA, Group LC, Group EC. Consensus statement on management of intersex disorders. Arch Dis Child. 2006;91(7):554-63.
7. Nabhan ZM, Lee PA. Disorders of sex development. Curr Opin Obstet Gynecol. 2007;19(5):440-5.
8. Kousta E, Papathanasiou A, Skordis N. Sex determination and disorders of the sex development according to the revised nomenclature and classifcation in 46,XX individuals. Hormones. 2010;9(3):218-31.
9. Mello M P, Assumpção JG, Hackel C. Genes involved in sex determination and differentiation. Arq Bras Endocrinol Metabol. 2005;49(1):14-25.
10. Ribeiro Scolfaro M, Aparecida Cardinalli I, Gabas Stuchi-Perez E, Palandi de Mello M, de Godoy Assumpção J, Matias Baptista M T, et al. Morphometry and histology of gonads from 13 children with dysgenetic male pseudohermaphroditism. Arch Pathol Lab Med. 2001;125(5):652-6.
11. Lipay MV, Bianco B, Verreschi I T. Disgenesias gonadais e tumores: aspectos genéticos e clínicos. Arq Bras Endocrinol Metabol. 2005;49(1):60-70.
12. Andrade JG, Guerra-Júnior G, Maciel-Guerra AT. 46,XY and 45,X/46,XY testicular dysgenesis: similar gonadal and genital phenotype, different prognosis. Arq Bras Endocrinol Metabol. 2010;54(3):331-4.
13. Gourlay WA, Johnson HW, Pantzar J T, McGillivray R, Crawford R, Nielsen W. Gonadal tumors in disorders of sexual differentiation. Urology. 1994;43(4):537-40.
14. Alvarez-Nava F, Puerta H, Soto M, Pineda L, Temponi A. High incidence of Y- chromosome microdeletions in gonadal tissues from patients with 45,X/46, XY gonadal dysgenesis Fertil Steril. 2008;89(2):458-60.
15. Biason-Lauber A. Control of sex development. Best Pract Res Clin Endocrinol Metab. 2010;24(2):163-86.
16. El-Khairi R, Martinez-Aguayo A, Ferraz-de-Souza B, Lin L, Acher-mann JC. Role of DAX-1 (NR0B1) and steroidogenic factor-1 (NR5A1) in human adrenal function. Endocr Dev. 2011;20:38-46.
17. Hanley NA, Ball SG, Clement-Jones M, Hagan DM, Strachan T, Lindsay S, et al. Expression of steroidogenic factor 1 and Wilms' tumour 1 during early human gonadal development and sex determination. Mech Dev. 1999;87(1-2):175-80.
18. Shen WH, Moore CCD, Ikeda Y, Parker KL, Holly AI. Nuclear receptor steroidogenic factor 1 regulates the Mullerian inhibiting substance gene: a link to the sex determination cascade. Cell. 1994;77(5):651-61.
19. Mlynarczuk J, Rekawiecki R. The role of the orphan receptor SF-1 in the development and function of the ovary. Reprod Biol. 2010;10(3):177-93.
20. Hoivik EA, Lewis AE, Aumo L, Bakke M. Molecular aspects of ste-roidogenic factor 1 (SF-1). Mol Cell Endocrinol. 2010;315(1-2):27-39.
21. Büdefeld T, Tobet SA, Majdic G. Steroidogenic factor 1 and the central nervous system. J Neuroendocrinol. 2011 Jun 11. doi: 10.1111/j.1365-2826.2011.02174.x. [Epub ahead of print].
22. Lala DS, Rice DA, Parker KL. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol Endocrinol. 1992;6(8):1249-58.
23. Parker KL, Rice DA, Lala DS, Ikeda Y, Luo X, Wong M, et al. Ste-roidogenic factor 1: an essential mediator of endocrine development. Recent Prog Horm Res. 2002;57:19-36.
24. Zimmermann S, Schwarzler A, Buth S, Engel W, Adham IM. Transcription of the Leydig insulin-like gene is mediated by steroidoge-nic factor-1. Mol Endocrinol. 1998;12(5):706-13.
25. Lin L, Achermann JC. Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development. Sex Dev. 2008;2(4-5):200-9.
26. Takayama K, Sasano H, Fukaya T, Morohashi K, Suzuki T, Tamu-ra M, et al. Immunohistochemical localization of Ad4 binding protein with correlation to steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors. J Clin Endocrinol Metab. 1995;80(9):2815-21.
27. Parker KL, Schimmer B P. Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr Rev. 1997;18(3):361-77.
28. Wong M, Ramayya MS, Chrousos G P, Driggers PH, Parker KL. Cloning and sequence analysis of the human gene encoding steroi-dogenic factor 1. J Mol Endocrinol. 1996;17(2):139-47.
29. Oba K, Yanase, T, Nomura M, Morohashi K, Takayanagi R, Nawata H. Structural characterization of human Ad4bp (SF-1) gene. Bio-chem Biophys Res Commun. 1996;226(1):261-7.
30. Little TH, Zhang Y, Matulis CK, Weck J, Zhang Z, Ramachandran A, et al. Sequence-specifc deoxyribonucleic acid (DNA) recognition by steroidogenic factor 1: a helix at the carboxy terminus of the DNA binding domain is necessary for complex stability. Mol En-docrinol. 2006;20(4):831-43.
31. Wilson TE, Fahrner TJ, Milbrandt J. The orphan receptors NGFI--B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol Cell Biol. 1993;13(9):5794-804.
32. Kimura R, Yoshii H, Nomura M, Kotomura N, Mukai T, Ishihara S, et al. Identifcation of novel frst exons in Ad4BP/SF-1 (NR5A1) gene and their tissue- and species-specifc usage. Biochem Bio-phys Res Commun. 2000;278(1):63-71.
33. Demura M, Wang F, Yoneda T, Karashima S, Mori S, Oe M, et al. Multiple noncoding exons 1 of nuclear receptors NR4A family (nerve growth factor-induced clone B, Nur-related factor 1 and neuron-derived orphan receptor 1) and NR5A1 (steroidogenic factor 1) in human cardiovascular and adrenal tissues. J Hyper-tens. 2011;29(6):1185-95.
34. Wood MA, Mukherjee P, Toocheck CA, Walker WH. Upstream stimulatory factor induces Nr5a1 and Shbg gene expression during the onset of rat sertoli cell differentiation. Biol Reprod. 2011;85(5):965-76. Epub 2011 Jul 6.
35. Hoivik EA, Bjanesoy TE, Mai O, Okamoto S, Minokoshi Y, Shima Y, et al. DNA methylation of intronic enhancers directs tissue-speci-fc expression of steroidogenic factor 1/adrenal 4 binding protein (SF-1/Ad4BP). Endocrinology. 2011;152(5):2100-12.
36. Luo X, Ikeda Y, Parker KL. A cell-specifc nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell. 1994;77:481-90.
37. Sadovsky Y, Crawford PA, Woodson KG, Polish JA, Clements MA, Tourtellotte LM, et al. Mice defcient in the orphan receptor ste-roidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc Natl Acad Sci USA. 1995;92(24):10939-43.
38. Achermann JC, Ito M, Hindmarsh PC, Jameson JL. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nature Genetics. 1999;22(2):125-6.
39. Ito M, Achermann JC, Jameson JL. A naturally occurring steroi-dogenic factor-1 mutation exhibits differential binding and activation of target genes. J Biol Chem. 2000;275(41):31708-14.
40. Achermann JC, Ozisik G, Ito M, Orun UA, Harmanci K, Gurakan B, et al. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic fac-tor-1, in a dose-dependent manner. J Clin Endocrinol Metab. 2002;87(4):1829-33.
41. Correa RV, Domenice S, Bingham NC, Billerbeck AEC, Rainey WE, Parker KL, et al. A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insuffciency. J Clin Endocrinol Metab. 2004;89(4):1767-72.
42. Mallet D, Bretones P, Michel-Calemard L, Dijoud F, David M, Morel Y. Gonadal dysgenesis without adrenal insuffciency in a 46,XY patient heterozygous for the nonsense C16X mutation: a case of SF1 haploinsuffciency. J Clin Endocrinol Metab. 2004;89:4829-32.
43. Tajima T, Fujiwara F, Fujieda K. A novel heterozygous mutation of steroidogenic factor-1 (SF-1/Ad4BP) gene (NR5A1) in a 46, XY disorders of sex development (DSD) patient without adrenal failure. Endocr J. 2009;56(4):619-24.
44. Lourenço D, Brauner R, Lin L, De Perdigo A, Weryha G, Muresan M, et al. Mutations in the NR5A1 associated with ovarian insuff-ciency. New Eng J Med. 2009;360(12):1200-10.
45. Soardi FC, Coeli FB, Maciel-Guerra AT, Guerra-Júnior G, De-Mello M P. Complete XY gonadal dysgenesis due to p.D293N homo-zygous mutation in the NR5A1 gene: a case study. J Appl Genet. 2010;51(2):223-4.
46. Ferraz-de-Souza B, Lin L, Achermann JC. Steroidogenic fac-tor-1 (SF-1, NR5A1) and human disease. Mol Cell Endocrinol. 2011;336(1-2):198-205.
47. Biason-Lauber A, Schoenle EJ. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insuff-ciency. Am J Hum Genet. 2000;67(6):1563-8.
48. Warman DM, Costanzo M, Marino R, Berensztein E, Galeano J, Ramirez PC, et al. Three new SF-1 (NR5A1) gene mutations in two unrelated families with multiple affected members: within-family variability in 46,XY subjects and low ovarian reserve in fertile 46,XX subjects. Horm Res Paediatr. 2011;75(1):70-7.
49. Bashamboo A, Ferraz-de-Souza B, Lourenço D, Lin L, Sebire NJ, Montjean D, et al. Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1. Am J Hum Genet. 2010;87(4):505-12.
50. Wuqiang F, Yanase T, Wei L, Oba K, Nomura M, Okabe T, et al. Functional characterization of a new human Ad4BP/SF-1 variation, G146A. Biochem Biophys Res Commun. 2003;311(4):987-94.
51. Philibert P, Zenaty D, Lin L, Soskin S, Audran F, Léger J, et al. Mu-tational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study. Hum Reprod. 2007;22(12):3255-61.
52. Brauner R, Neve M, Allali S, Trivin C, Lottmann H, Bashamboo A, et al. Clinical, biological and genetic analysis of anorchia in 26 boys. PLoS One. 2011;6(8):e23292. Epub 2011 Aug 10.
53. Philibert P, Leprieur E, Zenaty D, Thibaud E, Polak M, Frances AM, et al. Steroidogenic factor-1 (SF-1) gene mutation as a frequent cause of primary amenorrhea in 46,XY female adolescents with low testosterone concentration. Reprod Biol Endocrinol. 2010;8:28.